128 related articles for article (PubMed ID: 37985144)
1. Depth filtration for clarification of intensified lentiviral vector suspension cell culture.
Mayani M; Nellimarla S; Mangalathillam R; Rao H; Patarroyo-White S; Ma J; Figueroa B
Biotechnol Prog; 2024; 40(2):e3409. PubMed ID: 37985144
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
3. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
4. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.
Tona RM; Shah R; Middaugh K; Steve J; Marques J; Roszell BR; Jung C
Mol Ther Methods Clin Dev; 2023 Jun; 29():93-107. PubMed ID: 36994313
[TBL] [Abstract][Full Text] [Related]
5. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
6. Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum-free medium suspension cultures.
Vaz TA; Rodrigues AF; Coroadinha AS
Biotechnol J; 2024 Jan; 19(1):e2300212. PubMed ID: 37903159
[TBL] [Abstract][Full Text] [Related]
7. Transient Lentiviral Vector Production Using a Packed-Bed Bioreactor System.
McCarron A; Donnelley M; McIntyre C; Parsons D
Hum Gene Ther Methods; 2019 Jun; 30(3):93-101. PubMed ID: 31084376
[TBL] [Abstract][Full Text] [Related]
8. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
[TBL] [Abstract][Full Text] [Related]
9. Development of a perfusion process for continuous lentivirus production using stable suspension producer cell lines.
Klimpel M; Terrao M; Ching N; Climenti V; Noll T; Pirzas V; Laux H
Biotechnol Bioeng; 2023 Sep; 120(9):2622-2638. PubMed ID: 37148430
[TBL] [Abstract][Full Text] [Related]
10. A new simplified clarification approach for lentiviral vectors using diatomaceous earth improves throughput and safe handling.
Labisch JJ; Bollmann F; Wolff MW; Pflanz K
J Biotechnol; 2021 Jan; 326():11-20. PubMed ID: 33301854
[TBL] [Abstract][Full Text] [Related]
11. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
Tran MY; Kamen AA
Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066
[TBL] [Abstract][Full Text] [Related]
12. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
[TBL] [Abstract][Full Text] [Related]
13. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells.
Tirapelle MC; Oliveira Lomba AL; Silvestre RN; Mizukami A; Covas DT; Picanço-Castro V; Swiech K
Cytotherapy; 2022 Aug; 24(8):850-860. PubMed ID: 35643755
[TBL] [Abstract][Full Text] [Related]
14. Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy.
Tang QL; Gu LX; Xu Y; Liao XH; Zhou Y; Zhang TC
Bioengineered; 2021 Dec; 12(1):2095-2105. PubMed ID: 34047682
[TBL] [Abstract][Full Text] [Related]
15. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.
Lesch HP; Laitinen A; Peixoto C; Vicente T; Makkonen KE; Laitinen L; Pikkarainen JT; Samaranayake H; Alves PM; Carrondo MJ; Ylä-Herttuala S; Airenne KJ
Gene Ther; 2011 Jun; 18(6):531-8. PubMed ID: 21248790
[TBL] [Abstract][Full Text] [Related]
16. Development of Large-Scale Downstream Processing for Lentiviral Vectors.
Valkama AJ; Oruetxebarria I; Lipponen EM; Leinonen HM; Käyhty P; Hynynen H; Turkki V; Malinen J; Miinalainen T; Heikura T; Parker NR; Ylä-Herttuala S; Lesch HP
Mol Ther Methods Clin Dev; 2020 Jun; 17():717-730. PubMed ID: 32346549
[TBL] [Abstract][Full Text] [Related]
17. Insights into product and process related challenges of lentiviral vector bioprocessing.
Perry C; Mujahid N; Takeuchi Y; Rayat ACME
Biotechnol Bioeng; 2023 Aug; ():. PubMed ID: 37526313
[TBL] [Abstract][Full Text] [Related]
18. Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration.
Göbel S; Pelz L; Silva CAT; Brühlmann B; Hill C; Altomonte J; Kamen A; Reichl U; Genzel Y
Appl Microbiol Biotechnol; 2024 Feb; 108(1):240. PubMed ID: 38413399
[TBL] [Abstract][Full Text] [Related]
19. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
20. Process cost and facility considerations in the selection of primary cell culture clarification technology.
Felo M; Christensen B; Higgins J
Biotechnol Prog; 2013; 29(5):1239-45. PubMed ID: 23847160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]